Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus
Fei Tong,1,2 Suhuan Liu,1 Bing Yan,1 Xuejun Li,1 Shiwei Ruan,3 Shuyu Yang1 1Department of Endocrinology and Diabetes, The First Affiliated Hospital, Xiamen University, Xiamen, China; 2Department of Pathology and Pathophysiology, Provincial Key Discipline of Pharmacology, Jiaxing University Medical...
Main Authors: | Tong F, Liu S, Yan B, Li X, Ruan S, Yang S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-04-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/endogenous-ornithine-decarboxylasepolyamine-system-mediated-the-antago-peer-reviewed-article-IJN |
Similar Items
-
Polyamines directly promote antizyme-mediated degradation of ornithine decarboxylase by the proteasome
by: R. Roshini Beenukumar, et al.
Published: (2015-05-01) -
Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma
by: Laura Dawn Gamble, et al.
Published: (2012-11-01) -
Polyamines and related signaling pathways in cancer
by: Jiajing Li, et al.
Published: (2020-11-01) -
Molecular and Functional Consequences of Genetic Variability in the Ornithine Decarboxylase Gene in Colorectal Cancer
by: Prieto, Jenaro Garcia-Huidobro
Published: (2013) -
Difluoromethylornithine, a Decarboxylase 1 Inhibitor, Suppresses Hepatitis B Virus Replication by Reducing HBc Protein Levels
by: Binli Mao, et al.
Published: (2020-04-01)